Adults 21 to 29, any sex, with Alcohol Drinking or Binge Drinking. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Stop Signal Task (SST)Primary· Within an hour post-stimulation condition
The Stop-Signal Task (SST) is a task requiring inhibition of a prepotent motor response. The SST requires participants to respond to a target stimulus as quickly and accurately as possible by pressing a button, but also to withhold their response when they hear an auditory signal. Thus, this task involves a competition between activating and inhibiting processes. The primary outcome variable is change in the stop signal reaction time (SSRT) for the task administered seconds to minutes before and seconds to minutes after stimulation. The theoretical minimum is zero seconds and there is no theor
Group
Value
95% CI
Ethanol
255
± 463
Placebo (Juice)
215
± 278
Sponsor's own description
To evaluate the relationship of extraversion to both the acute subjective and behavioral effects of alcohol, and the neural reactivity to the anticipation of reward.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
NCT06819189 — Role of Metal Ion Transporter ZIP8 in Alcohol-Related Behaviors
· Phase 1
· recruiting
NCT06559878 — Hepatic Mitochondrial Metabolism in Fatty Liver Disease in Humans
· NA
· enrolling by invitation
NCT06065657 — Effect of Nutritional Ketosis on Alcohol Metabolism
· Phase 2, PHASE3
· active not recruiting
NCT06091189 — Internalized Stress in Relation to Alcohol Consumption
· EARLY_PHASE1
· terminated
NCT06143059 — The Effects of Sex Hormones and Alcohol on Sleep
· Phase 3
· suspended
Other recruiting trials for Alcohol Drinking
Currently open trials in the same condition.
NCT07415707 — The GLUCID Study: Effect of Alcohol Reduction and Probiotic Interventions on Cognition and Brain Glucose Metabolism in N
· NA
· recruiting
NCT06815237 — Effects of Ketone Supplement and Alcohol on Brain Metabolism
· Phase 2, PHASE3
· recruiting
NCT05363878 — Development of a Culturally Grounded, Trauma-Informed Alcohol Intervention With a Reserve-Dwelling First Nation Group
· NA
· recruiting
NCT06309134 — The Healthy Families Bright Futures Program
· NA
· recruiting
Other University of Chicago trials
Trials by the same sponsor.
NCT07346196 — A Trial of Locoregionally Advanced Squamous Cell Carcinoma of The Head and Neck
· Phase 2
· not yet recruiting
NCT07354100 — Lactulose to Improve Gut Health in Cancer Patients Receiving Immunotherapy
· Phase 1, PHASE2
· not yet recruiting
NCT06446661 — Using Text Messages to Improve Oral Chemotherapy for Adolescents and Adults With Acute Lymphoblastic Leukemia
· NA
· not yet recruiting
NCT07179315 — A Study Comparing Two Immunotherapy Options for Human Papillomavirus Positive HPV-Positive Head and Neck Cancer After Tr
· Phase 2
· not yet recruiting
NCT07126561 — Trastuzumab Deruxtecan to Treat HER2 + Newly Diagnosed Metastatic GI Cancers
· Phase 2
· not yet recruiting
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Chicago
Last refreshed: 25 April 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03930446.